Advertisement

Picture Consultech GmbH Secure Funding with RnD Grants v7 650x100px

News > All

Total search results: 6371 | Ordered by Source (ascending)
1 2 3 ... 62 63 64  next pagenext page

order ascendingorder descendingSource order ascendingorder descendingDate
10x Genomics Inc.. (1/7/19). "Press Release: 10x Genomics Lands New Financing". Pleasanton, CA. 2019-01-07
10x Genomics Inc.. (10/5/20). "Press Release: 10x Genomics Advances into Emerging Field of In Situ Analysis with Two Acquisitions". Pleasanton, CA. 2020-10-05
10x Genomics Inc.. (2/24/21). "Press Release: 10x Genomics Showcases Next Wave of Innovations at First Ever Xperience Event. Acquires Tetramer Shop, Reveals Details on Upcoming Products". Pleasanton, CA. 2021-02-24
2cureX AB. (1/28/21). "Press Release: 2cureX Appoints Kenneth Graabek Johansen, an Experienced Business and Financial Executive, as New CFO". Copenhagen. 2021-01-28
3B Pharmaceuticals GmbH. (4/24/23). "Press Release: 3B Pharmaceuticals Enters into a Global Exclusive Licensing Agreement for its FAP-Targeting Peptide Technology". Berlin. 2023-04-24
3D Systems, Inc.. (2/23/22). "Press Release: 3D Systems to Expand Healthcare Applications Portfolio with Acquisition of Kumovis". Rock Hill, SC. 2022-02-23
3P Biopharmaceuticals S.L.. (7/23/19). "Press Release: 3P Biopharmaceuticals Welcomes Keensight Capital as Majority Shareholder". Paris. 2019-07-23
4basebio AG. (7/28/20). "Press Release: 4basebio Informs about Takeover Bid by Sparta AG". Heidelberg & Cambridge. 2020-07-28
4BIO Capital (4BIO Ventures Management Ltd.). (9/9/19). "Press Release: 4BIO Capital Raises $50 million in First Close of New Advanced Therapies Fund". London & Boston, MA. 2019-09-09
4D Lifetec AG. (10/18/23). "Press Release: 4D Lifetec Secures CHF 23.3 Mio in a Share and Investment Deal with Xlife Sciences Opening New Horizons in Using AI and Digital Health in Early Cancer Detection". Zürich & Cham. 2023-10-18
4D Lifetec AG. (7/11/22). "Press Release: 4D Lifetec Announces Successful First closing of CHF 1.9 Million Series B Financing to Launch Its Early Lung Cancer Detection Liquid Biopsy Assay 4D Lifetest Lung Dx in Europe". Cham. 2022-07-11
4D Pharma plc. (10/8/19). "Press Release: 4D Pharma Collaborates with MSD to Develop Live Biotherapeutics for Vaccines". 2019-10-08
4SC AG. (10/18/23). "Press Release: 4SC Receives Orphan Drug Designation (ODD) for Resminostat (Kinselby) in CTCL in the European Union". Planegg-Martinsried. 2023-10-18
4SC AG. (10/7/19). "Press Release: 4SC AG Resolves to Issue New Shares, Santo and ATS Undertake to Subscribe / Buy the New Shares [Not for US, AU, CA, et al.]". Planegg-Martinsried. 2019-10-07
4SC AG. (11/12/19). "Press Release: 4SC AG Secures circa EUR 22.4 Million from a Capital Increase [Not for release in US, Australia, Canada, et al.]". Planegg-Martinsried. 2019-11-12
4SC AG. (11/25/20). "Press Release: 4SC AG Resolves to Issue New Shares with Expected Proceeds of approx. EUR 7.5 Million (ad hoc) [not for US, AU, CA, JP, ZA, et al.]". Planegg-Martinsried. 2020-11-25
4SC AG. (2/6/19). "Press Release: First Patient Enrolled in Phase II Study EMERGE of Domatinostat (4SC-202) in Gastrointestinal Cancer". Planegg-Martinsried. 2019-02-06
4SC AG. (3/20/19). "Press Release: 4SC AG Provides Results for Financial Year 2018 and Outlook". Planegg-Martinsried. 2019-03-20
4SC AG. (6/28/19). "Press Release: 4SC AG Secures EUR 11 Million from Capital Increase [Ad hoc, not for US, AU, CA, JP, ZA, et al.]". Planegg-Martinsried. 2019-06-28
4SC AG. (9/11/20). "Press Release: 4SC and Maruho Discontinue Collaboration for Development of 4SC’s Kv1.3 Inhibitors". Planegg-Martinsried. 2020-09-11
4SC AG. (9/27/23). "Press Release: 4SC Receives Orphan Drug Designation (ODD) for Resminostat (Kinselby) in CTCL from the US FDA". Planegg-Martinsried. 2023-09-27
4Teen4 Pharmaceuticals GmbH. (12/5/19). "Press Release: Biotech Startup 4Teen4 Pharmaceuticals Closes EUR 7 Million Series A Financing". Hennigsdorf. 2019-12-05
77 Foods SAS (d/b/a La Vie Foods). (1/19/22). "Press Release: The Start-up La Vie Raises €25M and Sets Out to Conquer the World with Its New Generation of Plant-based Meat". Paris. 2022-01-19
908 Devices, Inc.. (1/7/22). "Press Release: 908 Devices Announces GSK Purchases Fifth Rebel Cell Culture Media Analyzer". Boston, MA. 2022-01-07
908 Devices, Inc.. (6/22/21). "Press Release: 908 Devices Announces New Data Integrations with Key Industry Partners to Accelerate BioProcess Data Insights". Boston, MA. 2021-06-22
908 Devices, Inc.. (6/3/19). "Press Release: 908 Devices Broadens the ZipChip Platform, Brings New Capability to Biotherapeutics Researchers". Boston, MA. 2019-06-03
908 Devices, Inc.. (7/25/19). "Press Release: 908 Devices Poised to Modernize Upstream Bioprocess Analytics with a Grant from the National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL)". Boston, MA. 2019-07-25
908 Devices, Inc.. (8/9/22). "Press Release: 908 Devices Acquires Trace Analytics, Enabling On-line Bioanalytics". Boston, MA. 2022-08-09
A2 Biotherapeutics, Inc.. (10/6/20). "Press Release: A2 Biotherapeutics Closes $71.5m Series B to Begin Clinical Development of Its Potentially TransformativeSelective Tumor Cell Therapeutics". Agoura Hills, CA. 2020-10-06
A2 Biotherapeutics, Inc.. (11/5/19). "Press Release: A2 Biotherapeutics Emerges from Stealth Mode with $57m Series A to Develop a Pipeline of Selective Tumor Cell Therapeutics". Agoura Hills, CA. 2019-11-05
A2 Biotherapeutics, Inc.. (3/25/24). "Press Release: A2 Bio Appoints James Robinson as New Chief Executive Officer and Member of the Board of Directors". Agoura Hills, CA. 2024-03-25
AATec Medical GmbH. (10/31/23). "Press Release: AATec Medical and Beurer Enter Development Collaboration for Inhaled Alpha-1 Antitrypsin". Munich. 2023-10-31
AATec Medical GmbH. (7/17/23). "Press Release: AATec Medical Announces Its Launch with EUR 2.7 Million in Seed Financing to Unlock the Therapeutic Potential of Alpha-1 Antitrypsin". Munich. 2023-07-17
AAVantgarde Bio S.r.l.. (6/6/23). "Press Release: AAVantgarde Closes €61 Million Series A Financing to Advance Two Therapeutic Programs into the Clinic". Milan. 2023-06-06
AAVantgarde Bio S.r.l.. (9/8/22). "Press Release: AAVantgarde Bio Appoints Dr. Natalia Misciattelli as Chief Executive Officer". Milan. 2022-09-08
AaviGen GmbH. (7/26/23). "Press Release: AaviGen Raises 17 Million € in Second Financing Round to Advance Precision Gene Therapies for Heart Failure towards the Clinical Stage". Heidelberg. 2023-07-26
AAX Biotech AB. (11/28/23). "Press Release: AAX Biotech Forms Strategic Collaboration with Oblique Therapeutics for Therapeutic Antibody Development". 2023-11-28
AAX Biotech AB. (9/28/23). "Press Release: AAX Biotech Welcomes New CEO to Drive Advancements in Next-generation Antibody Therapeutics". 2023-09-28
AB Science S.A.. (2/28/22). "Press Release: Financing of 8.5 Million Dollars through the Issuance of Convertible Bonds with Attached Warrants (with a Conversion Price of EUR 14.0) [Not for US, CA, AU or JP]". Paris. 2022-02-28
AB Sciex (d/b/a Sciex). (11/1/21). "Press Release: Sciex and Evosep Will Collaborate to Provide Robust, High-throughput Proteomics Workflows". 2021-11-01
AB Sciex (d/b/a Sciex). (9/23/19). "Press Release: Sciex Medical Devices Set to Address the Challenges faced by Brazil’s Clinical Diagnostics Laboratories". São Paulo. 2019-09-23
AB Sciex (d/b/a Sciex). (9/5/19). "Press Release: Sciex Launches Partner Portal to Support Customer Needs Worldwide and Extend Network". Framingham, MA. 2019-09-05
Abalos Therapeutics GmbH. (10/14/21). "Press Release: Abalos Therapeutics Completes Series A Extension Bringing Total Raised to EUR 43 Million". Düsseldorf. 2021-10-14
Abalos Therapeutics GmbH. (10/15/19). "Press Release: Abalos Therapeutics Launches with €12M Series A Round to Develop Novel Immuno-Virotherapies Against Cancer". Essen. 2019-10-15
AbbVie Inc.. (1/25/19). "Press Release: AbbVie Reports Full-Year and Fourth-Quarter 2018 Financial Results". North Chicago, IL. 2019-01-25
AbbVie Inc.. (10/20/22). "Press Release: AbbVie Acquires DJS Antibodies, Further Strengthening Immunology Pipeline". North Chicago, IL. 2022-10-20
AbbVie Inc.. (3/1/22). "Press Release: AbbVie Acquires Syndesi Therapeutics, Strengthening Neuroscience Portfolio". North Chicago, IL. 2022-03-01
AbbVie Inc.. (6/25/19). "Press Release: AbbVie to Acquire Allergan in Transformative Move for Both Companies". 2019-06-25
Abcam plc. (10/23/20). "Press Release: Abcam Announces Exercise of Over-allotment Option [not for any jurisdiction where a violation of relevant laws]". London. 2020-10-23
Abcam plc. (10/23/20). "Press Release: Abcam Announces Launch of Offering and Application to List on the Nasdaq Global Market". London. 2020-10-23
Abcam plc. (10/23/20). "Press Release: Abcam Announces Pricing of Offering on Nasdaq". London. 2020-10-23
Abcam plc. (6/23/23). "Press Release: Abcam Announces Review of Strategic Alternatives". Cambridge & Waltham, MA. 2023-06-23
Abcam plc. (8/2/21). "Press Release: Abcam to Acquire BioVision for $340 Million". Cambridge. 2021-08-02
AbCellera Biologics, Inc.. (2/14/19). "Press Release: AbCellera Announces Multi-Target Partnership Agreement with a Top 5 Global Pharma". Vancouver, BC. 2019-02-14
Aber Instruments. (2/1/21). "Press Release: Aber Instruments Acquires BugLab to Consolidate its World-leading Biomass Monitoring Portfolio". Alexandria, VA. 2021-02-01
Aber Instruments. (3/22/21). "Press Release: Aber Introduces Futura neotf On-line Single-use Biomass Sensor". Aberystwyth. 2021-03-22
Abera Bioscience AB. (3/29/22). "Press Release: Abera Bioscience Signs Agreement with NorthX Biologics for GMP Manufacturing". 2022-03-29
Abingworth LLP. (10/30/23). "Press Release: Abingworth Raises $356 Million for New Clinical Co-Development Co-Investment Fund (CCD-CIF)". London & New York, NY. 2023-10-30
Abingworth LLP. (2/3/21). "Press Release: Abingworth Raises $465m for New Life Sciences Fund Abingworth Bioventures 8". London. 2021-02-03
Abingworth LLP. (5/10/21). "Press Release: Abingworth Raises $582 Million for New Clinical Co-Development Fund – ACCD 2". London. 2021-05-10
Abingworth LLP. (9/15/21). "Press Release: Abingworth Strengthens Investment Team with New Appointments in the US and UK". London. 2021-09-15
Abionic S.A.. (9/13/19). "Press Release: International Pivotal Study Successfully Demonstrates Diagnosis of Sepsis within 5 Minutes – 24 Hours Earlier Compared with Current Standard-of-Care". Lausanne. 2019-09-13
Abionic S.A.. (9/5/19). "Press Release: Abionic Signs Agreement to Optimize Asthma Management in the U.S. through Innovative Rapid Point-of-Care Tests". Lausanne. 2019-09-05
Abionyx Pharma S.A.. (7/13/23). "Press Release: Abionyx Pharma Announces the Appointment of Laurent Guerci as Chief Digital & Innovation Officer". Toulouse & Lakeland, MI. 2023-07-13
Abionyx Pharma S.A.. (8/27/19). "Press Release: Change of Name and Stock Symbol/Mnemonic of Abionyx Pharma Shares (formerly Cerenis Therapeutics) as of August 29, 2019". Toulouse & Lakeland, US. 2019-08-27
Abionyx Pharma S.A.. (9/9/19). "Press Release: Cyrille Tupin Appointed CEO". Toulouse & Lakeland, US. 2019-09-09
Abivax S.A.. (10/20/23). "Press Release: Abivax Announces the Pricing of Its Initial Public Offering on the Nasdaq Global Market". Paris. 2023-10-20
Abivax S.A.. (10/24/23). "Press Release: Abivax Announces Closing of its Initial Public Offering on the Nasdaq Global Market". Paris. 2023-10-24
Abivax S.A.. (3/11/19). "Press Release: Abivax Presents Impressive New Phase 2a ABX464 Ulcerative Colitis 6-Months Maintenance Study Data in Oral Plenary Session at Annual Congress of European Crohn’s and Colitis Organisation (ECCO)". Paris. 2019-03-11
Abivax S.A.. (3/14/19). "Press Release: Abivax 2018 Financial Results and Operations Update". Paris. 2019-03-14
Abivax S.A.. (6/23/21). "Press Release: Abivax Reports Excellent Phase 2a Clinical Safety and Efficacy Results with 50mg ABX464 in Rheumatoid Arthritis". Paris. 2021-06-23
Abivax S.A.. (7/11/23). "Press Release: Abivax Announces the Appointment of June Lee, M.D. and Troy Ignelzi as Members of the Board of Directors". Paris. 2023-07-11
Abivax S.A.. (7/23/21). "Press Release: Abivax Announces the Pricing of Its Oversubscribed Capital Increase of EUR 60M and Convertible Bonds of EUR 25M, Totaling EUR 85M New Financing". Paris. 2021-07-23
Abivax S.A.. (8/21/23). "Press Release: Abivax Secures Up to EUR 150M from Two Structured Debt Financing Transactions". Paris. 2023-08-21
Abivax S.A.. (8/23/23). "Press Release: Abivax Appoints Patrick Malloy as Senior Vice President Investor Relations". Paris. 2023-08-23
Abivax S.A.. (9/2/22). "Press Release: Abivax Announces Successful Oversubscribed EUR 49.2M Cross-over Financing with Top-tier US and European Biotech Investors [not for US]". Paris. 2022-09-02
Abivax S.A.. (9/29/23). "Press Release: Abivax Files Registration Statement for Proposed Initial Public Offering in the United States". Paris. 2023-09-29
ABL Biomanufacutring. (3/27/23). "Press Release: ABL Appoints Stéphanie Colloud as General Manager and Chief Operating Officer to Lead European Activities". Lyon. 2023-03-27
Aboleris Pharma. (9/18/23). "Press Release: Aboleris Pharma Announces €27 Million in Series A Financing to Advance its Novel Treatment Paradigm for Autoimmune and Inflammatory Diseases". Gosselies. 2023-09-18
Abzena Ltd.. (1/20/22). "Press Release: Abzena Appoints Jim Kennamer as SVP and Site Head of North Carolina". Cambridge & San Diego, CA. 2022-01-20
Abzena Ltd.. (2/1/22). "Press Release: Abzena Appoints Kevin Lundquist as Chief Financial Officer". Cambridge & San Diego, CA. 2022-02-01
Abzena Ltd.. (3/31/22). "Press Release: Abzena Secures $65 Million in Additional Funding to Accelerate Growth and Expand Capacity". San Diego, CA. 2022-03-31
Abzena Ltd.. (6/6/23). "Press Release: Abzena Appoints Thomas Castellano as Chief Financial Officer". San Diego, CA. 2023-06-06
Abzena Ltd.. (7/28/20). "Press Release: Abzena Receives Growth Capital Investment from Newly Launched Biospring Partners". Cambridge, Bristol, PA & San Diego, CA. 2020-07-28
AC Immune S.A.. (1/30/19). "Press Release: AC Immune Reports Discontinuation of Phase III CREAD 1 and 2 Studies of Crenezumab in Alzheimer’s Disease". Lausanne. 2019-01-30
AC Immune S.A.. (12/15/23). "Press Release: AC Immune Announces Pricing of Underwritten Offering of Common Shares". Lausanne. 2023-12-15
AC Immune S.A.. (12/15/23). "Press Release: AC Immune Strengthens Management, Appoints Madiha Derouazi as CSO and Christopher Roberts as CFO". Lausanne. 2023-12-15
AC Immune S.A.. (3/21/19). "Press Release: AC Immune Reports Full-Year 2018 Financial Results and Provides Business Update". Lausanne. 2019-03-21
AC Immune S.A.. (3/23/20). "Press Release: AC Immune Receives Second Milestone and New Milestone to Increase the Potential Deal Value of Lilly Morphomer Tau Partnership". Lausanne. 2020-03-23
AC Immune S.A.. (5/13/24). "Press Release: AC Immune and Takeda Sign Exclusive Option and License Agreement for Active Immunotherapy Targeting Amyloid Beta for Alzheimer’s Disease". Osaka, Cambride, MA & Lausanne. 2024-05-13
AC Immune S.A.. (6/27/23). "Press Release: AC Immune Receives FDA Fast Track Designation for Anti-Amyloid-beta Active Immunotherapy, ACI-24.060, to Treat Alzheimer’s Disease". Lausanne. 2023-06-27
AC Immune S.A.. (7/27/21). "Press Release: AC Immune Announces Strategic Acquisition of Industry-leading Parkinson’s Disease Vaccine Candidate and Equity Investment Led by Athos Service GmbH". Lausanne. 2021-07-27
AC Immune S.A.. (8/12/19). "Press Release: AC Immune Announces Research Collaboration with University of Pennsylvania Focusing on Pathogenic Protein TDP-43 in Neurodegenerative Diseases". Lausanne. 2019-08-12
AC Immune S.A.. (8/5/20). "Press Release: AC Immune Reports Q2 2020 Financial Results and Provides Business Update". Lausanne. 2020-08-05
AC Immune S.A.. (9/17/19). "Press Release: AC Immune Receives Milestone Payment in Connection with Initiation of a Phase 2 Trial of Tau PET Tracer PI-2620". Lausanne. 2019-09-17
AC Immune S.A.. (9/20/19). "Press Release: AC Immune Receives First Milestone Payment from Lilly in Small Molecule Tau Morphomer Program". Lausanne. 2019-09-20
AC Immune S.A.. (9/4/19). "Press Release: AC Immune Awarded Michael J. Fox Foundation Grant to Accelerate Development of Parkinson’s Disease Diagnostic Imaging Agent". Lausanne. 2019-09-04
Accession Therapeutics Ltd.. (1/26/22). "Press Release: Cancer Leader Professor Alan Parker Joins Accession Therapeutics. Co-inventor of Trocept platform to Guide Immuno-oncology Pipeline Growth". Oxford. 2022-01-26
Accession Therapeutics Ltd.. (11/21/22). "Press Release: Accession Therapeutics Raises £16.6m to Advance Potent Immunotherapies towards Clinical Trials". Oxford. 2022-11-21
Accession Therapeutics Ltd.. (7/19/23). "Press Release: Chief Business Officer Appointed at Accession Therapeutics as Company Prepares for Clinical Trials". Oxford. 2023-07-19
1 2 3 ... 62 63 64  next pagenext page



Advertisement

Picture Consultech GmbH Secure Funding with RnD Grants 650x200px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]


Advertisement

Picture Consultech GmbH Secure Funding with RnD Grants 650x300px

» top